These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31526281)

  • 1. Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, patient controlled, reversible birth control method.
    Nelson AL
    Expert Rev Clin Pharmacol; 2019 Oct; 12(10):953-963. PubMed ID: 31526281
    [No Abstract]   [Full Text] [Related]  

  • 2. Contraceptive vaginal ring containing segesterone acetate and ethinyl estradiol: long-acting, patient-controlled, procedure-free, reversible prescription birth control.
    Paton DM
    Drugs Today (Barc); 2019 Jul; 55(7):449-457. PubMed ID: 31347613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A technology evaluation of Annovera: a segesterone acetate and ethinyl estradiol vaginal ring used to prevent pregnancy for up to one year.
    Micks EA; Jensen JT
    Expert Opin Drug Deliv; 2020 Jun; 17(6):743-752. PubMed ID: 32410464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segesterone Acetate and Ethinyl Estradiol Vaginal Ring (Annovera) for Contraception.
    Lee AL
    Am Fam Physician; 2020 May; 101(10):618-620. PubMed ID: 32412221
    [No Abstract]   [Full Text] [Related]  

  • 5. Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation.
    Gemzell-Danielsson K; Sitruk-Ware R; Creinin MD; Thomas M; Barnhart KT; Creasy G; Sussman H; Alami M; Burke AE; Weisberg E; Fraser I; Miranda MJ; Gilliam M; Liu J; Carr BR; Plagianos M; Roberts K; Blithe D
    Contraception; 2019 Jun; 99(6):323-328. PubMed ID: 30831102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
    Weisberg E; Fraser IS; Mishell DR; Lacarra M; Darney P; Jackanicz TM
    Contraception; 1999 May; 59(5):305-10. PubMed ID: 10494484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annovera - a new contraceptive vaginal ring.
    Med Lett Drugs Ther; 2019 Dec; 61(1587):197-198. PubMed ID: 31999667
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
    Weisberg E; Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Nash HA
    Contraception; 1999 May; 59(5):311-8. PubMed ID: 10494485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Year-Long Combination Hormonal Contraceptive.
    Blakely KK
    Nurs Womens Health; 2019 Apr; 23(2):172-176. PubMed ID: 30836070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials.
    Archer DF; Merkatz RB; Bahamondes L; Westhoff CL; Darney P; Apter D; Jensen JT; Brache V; Nelson AL; Banks E; Bártfai G; Portman DJ; Plagianos M; Dart C; Kumar N; Creasy GW; Sitruk-Ware R; Blithe DL
    Lancet Glob Health; 2019 Aug; 7(8):e1054-e1064. PubMed ID: 31231065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of concurrent vaginal miconazole treatment on the absorption and exposure of Nestorone® (segesterone acetate) and ethinyl estradiol delivered from a contraceptive vaginal ring: a randomized, crossover drug-drug interaction study.
    Simmons KB; Kumar N; Plagianos M; Roberts K; Hoskin E; Han L; Alami M; Creasy G; Variano B; Merkatz R
    Contraception; 2018 Mar; 97(3):270-276. PubMed ID: 29097225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring.
    Weisberg E; Fraser IS; Lacarra M; Mishell DR; Jackanicz T
    Contraception; 1997 Oct; 56(4):233-9. PubMed ID: 9408704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with nonadherence to instructions for using the Nestorone®/ethinyl estradiol contraceptive vaginal ring.
    Stifani BM; Plagianos M; Vieira CS; Merkatz RB
    Contraception; 2018 May; 97(5):415-421. PubMed ID: 29269252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetate.
    Chen MJ; Creinin MD; Turok DK; Archer DF; Barnhart KT; Westhoff CL; Thomas MA; Jensen JT; Variano B; Sitruk-Ware R; Shanker A; Long J; Blithe DL
    Contraception; 2020 Sep; 102(3):168-173. PubMed ID: 32416145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segesterone acetate serum levels with a regression model of continuous use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system.
    Liu JH; Plagianos M; Archer DF; Simon JA; Kaunitz AM; Graham S; Bernick B; Mirkin S
    Contraception; 2021 Sep; 104(3):229-234. PubMed ID: 33785318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Lasting, Patient-Controlled, Procedure-Free Contraception: A Review of Annovera with a Pharmacist Perspective.
    Virro JJ; Besinque K; Carney CE; Gross D; Bernick B; Mirkin S
    Pharmacy (Basel); 2020 Aug; 8(3):. PubMed ID: 32872116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding profile associated with 1-year use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system: pooled analysis from Phase 3 trials.
    Vieira CS; Fraser IS; Plagianos MG; Burke AE; Westhoff CL; Jensen J; Brache V; Bahamondes L; Merkatz R; Sitruk-Ware R; Blithe DL
    Contraception; 2019 Dec; 100(6):438-444. PubMed ID: 31398307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
    Alvarez-Sanchez F; Brache V; Jackanicz T; Faundes A
    Contraception; 1992 Oct; 46(4):387-98. PubMed ID: 1486777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility study of Nestorone-ethinylestradiol vaginal contraceptive ring for emergency contraception.
    Croxatto HB; Brache V; Massai R; Alvarez F; Forcelledo ML; Pavez M; Cochon L; Salvatierra AM; Faundes A
    Contraception; 2006 Jan; 73(1):46-52. PubMed ID: 16371294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone® and estradiol: pharmacokinetics from a dose-finding study.
    Jensen JT; Edelman AB; Chen BA; Archer DF; Barnhart KT; Thomas MA; Burke AE; Westhoff CL; Wan LS; Sitruk-Ware R; Kumar N; Variano B; Blithe DL
    Contraception; 2018 May; 97(5):422-427. PubMed ID: 29409834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.